Selling

Federal Reserve holdings of mortgage bonds serve a pivotal role in how monetary policy affects the economy’s momentum, as highlighted in a recent paper presented at a central bank research conference. The paper delves into the significance of how the Fed utilizes increases and contractions in its holdings of Treasury and mortgage bonds to complement
0 Comments
Bank of America’s stock took a hit, falling 2% after Warren Buffett’s Berkshire Hathaway revealed it was further reducing its stake in the bank. This news comes after a 12-day selling streak that started in mid-July, with the conglomerate selling 13.9 million more shares for $550.7 million over the past three trading days. Berkshire’s stake
0 Comments
General Motors recently unveiled the redesigned versions of its entry-level GMC Terrain crossover, showcasing a more rugged exterior design. This new look is sure to turn heads on the road, providing a fresh and modern aesthetic for consumers who are in the market for a compact crossover. One of the most notable updates to the
0 Comments
The cryptocurrency market experienced significant volatility as Bitcoin dropped below $50,000 for the first time since February. This led to a ripple effect on bitcoin-related companies, with names like Robinhood, MicroStrategy, Coinbase, and Marathon Digital all facing losses. Robinhood plummeted more than 10%, while MicroStrategy plunged more than 8%. This highlights how closely tied these
0 Comments
In the last quarter, Berkshire Hathaway’s cash pile swelled to a record $276.9 billion, marking a significant increase from the previous record of $189 billion set in the first quarter of 2024. This surge came as Warren Buffett, the Oracle of Omaha, sold off large portions of stock holdings, including a significant portion of his
0 Comments
Moderna, a prominent biotech company, recently reported second-quarter revenue that exceeded expectations. However, the company decided to reduce its full-year sales guidance due to various factors such as lower expected sales in Europe, a competitive environment for respiratory vaccines in the U.S., and the potential for deferred international revenue into 2025. The company now anticipates
0 Comments